Ann: 2023 Annual Report to shareholders, page-183

Surely if the upcoming trial results are good, any takeover offer put forward would have to spark a bidding war. Jon has mentioned on a few occasions there has been interest from several parties about NA rights to 2591, so it makes sense to me there would be more than one suitor interested in a takeover.

Like others I'm keenly interested to see how the sp will react in response to good results from the trials, but this is the ASX and it is very miserly in attributing fair value so I remain reserved in my expectations. I'd like to think that if the sp tracks towards $30-40 in response to good results from PH and Angleman then larger shareholders will possibly recalibrate their expectations and selling points to a higher level because the market is responding favourably. A 100% premium puts the stock in a $60 -80 range in relatively short order. A few months' wait could change everything...